Urban-rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi’an, China.

Publication date: May 28, 2026

Cervical cancer remains a major public health challenge in China, with persistent urban-rural disparities in screening coverage. The epidemiological landscape of HPV genotype distribution and screening outcomes across geographic settings remains incompletely characterized. We compared HPV prevalence, genotype distribution, and screening outcomes between urban and rural populations in Xi’an, China, during the post-COVID-19 pandemic period (2023-2025). This retrospective cross-sectional study analysed HPV testing records from 16,365 women (11,449 urban, 4,916 rural) screened between January 2023 and December 2025. Primary urban-rural comparisons were restricted to the 15 high-risk genotypes common to both detection platforms (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68). Histopathological follow-up was characterised within the rural sub-cohort only (matched urban cascade data unavailable). Statistical analyses included chi-square with Bonferroni correction, Wilson 95% CIs, and network analysis for co-infection patterns; significance set at p 

Open Access PDF

Concepts Keywords
China Cervical cancer screening
Pandemic China
Rural Co-infection
Follow-up adherence
Healthcare equity
HPV genotype
HPV52
Human papillomavirus
Urban–rural disparity

Semantics

Type Source Name
disease MESH cervical cancer
disease MESH COVID-19 pandemic
disease MESH included
disease MESH co-infection
disease MESH Infectious Diseases
disease MESH Dis
pathway REACTOME Reproduction
disease MESH infections
disease MESH Persistent infection
disease MESH HPV infection
disease MESH cervical intraepithelial neoplasia
disease MESH Low grade squamous intraepithelial lesions
drug DRUGBANK Acetic acid
disease MESH face

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *